Otonomy Inc. (OTIC) OTC MARKETS
$0.08 - (-)
Market Cap: -
As of 12/22/22 12:00 AM EST. Market closed.
Otonomy Inc. (OTIC)
OTC MARKETS
$0.08
- (-)
Market Cap: -
As of 12/22/22 12:00 AM EST. Market closed.
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products ... read more
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Weber David Allen | Director | Dec 30, 2022 | Option Exercise | $0.09 | 91,636 | 8,064 | 285,863 | Dec 30, 2022, 04:31 PM |
Cayer Paul E | President and CFBO | Dec 28, 2022 | Option Exercise | $0.09 | 40,054 | 3,485 | 183,733 | Dec 30, 2022, 04:30 PM |
CAPPS VICKIE L | Director | Nov 28, 2022 | Sale | $0.10 | 42,242 | 4,342 | 3,400 | Nov 29, 2022, 04:18 PM |
Weber David Allen | President & CEO | Mar 28, 2022 | Sale | $2.41 | 11,243 | 27,129 | 377,499 | Mar 29, 2022, 08:59 PM |
Weber David Allen | President & CEO | Mar 25, 2022 | Sale | $2.39 | 8,026 | 19,166 | 388,742 | Mar 29, 2022, 08:59 PM |
Savel Robert Michael II | Chief Technical Officer | Mar 28, 2022 | Sale | $2.41 | 3,325 | 8,023 | 145,735 | Mar 29, 2022, 08:58 PM |
Savel Robert Michael II | Chief Technical Officer | Mar 25, 2022 | Sale | $2.39 | 2,374 | 5,669 | 149,060 | Mar 29, 2022, 08:58 PM |
Foster Alan Charles | Chief Scientific Officer | Mar 28, 2022 | Sale | $2.41 | 2,559 | 6,175 | 177,017 | Mar 29, 2022, 08:54 PM |
Foster Alan Charles | Chief Scientific Officer | Mar 25, 2022 | Sale | $2.39 | 1,827 | 4,363 | 179,576 | Mar 29, 2022, 08:54 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Mar 28, 2022 | Sale | $2.41 | 5,624 | 13,571 | 223,787 | Mar 29, 2022, 08:53 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Mar 25, 2022 | Sale | $2.39 | 4,015 | 9,588 | 229,411 | Mar 29, 2022, 08:53 PM |
Lichter Jay | Director | Mar 03, 2021 | Sale | $2.70 | 321,180 | 866,544 | 0 | Mar 03, 2021, 08:06 PM |
Lichter Jay | Director | Mar 01, 2021 | Sale | $2.86 | 173,700 | 496,087 | 458,620 | Mar 02, 2021, 07:51 PM |
Lichter Jay | Director | Feb 26, 2021 | Sale | $2.83 | 330,554 | 935,468 | 570,701 | Mar 02, 2021, 07:51 PM |
Lichter Jay | Director | Mar 02, 2021 | Sale | $2.90 | 389,574 | 1,129,375 | 207,245 | Mar 02, 2021, 07:51 PM |
Lichter Jay | Director | Feb 25, 2021 | Sale | $2.95 | 311,100 | 918,989 | 783,993 | Feb 25, 2021, 09:56 PM |
Lichter Jay | Director | Feb 24, 2021 | Sale | $2.98 | 503,135 | 1,500,349 | 984,732 | Feb 25, 2021, 09:56 PM |
Lichter Jay | Director | Feb 23, 2021 | Sale | $2.89 | 268,118 | 774,325 | 1,309,383 | Feb 25, 2021, 09:56 PM |
Lichter Jay | Director | Aug 31, 2017 | Option Exercise | $18.37 | 108,851 | 1,999,593 | 2,297,361 | Sep 05, 2017, 06:38 PM |
Lichter Jay | Director | Aug 31, 2017 | Option Exercise | $14.18 | 141,060 | 2,000,231 | 2,406,212 | Sep 05, 2017, 06:38 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Jun 01, 2017 | Option Exercise | $11.43 | 1,206 | 13,785 | 3,522 | Jun 27, 2017, 05:09 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Dec 01, 2016 | Option Exercise | $13.05 | 647 | 8,443 | 2,316 | Jun 27, 2017, 05:09 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Jun 01, 2016 | Option Exercise | $13.13 | 1,021 | 13,406 | 1,669 | Jun 27, 2017, 05:09 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Dec 01, 2015 | Option Exercise | $20.37 | 648 | 13,200 | 648 | Jun 27, 2017, 05:09 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Jun 26, 2017 | Sale | $18.75 | 1,206 | 22,613 | 0 | Jun 27, 2017, 05:09 PM |
LOUMEAU ERIC J | GC & Chief Compliance Officer | Jun 23, 2017 | Sale | $18.50 | 2,316 | 42,846 | 1,206 | Jun 27, 2017, 05:09 PM |
LeBel Carl | Chief Scientific Officer | Nov 21, 2016 | Option Exercise | $3.17 | 1,456 | 4,616 | 10,914 | Nov 22, 2016, 05:57 PM |
LeBel Carl | Chief Scientific Officer | Nov 18, 2016 | Option Exercise | $4.39 | 9,169 | 40,262 | 18,627 | Nov 22, 2016, 05:57 PM |
LeBel Carl | Chief Scientific Officer | Nov 21, 2016 | Sale | $18.07 | 1,456 | 26,303 | 9,458 | Nov 22, 2016, 05:57 PM |
LeBel Carl | Chief Scientific Officer | Nov 18, 2016 | Sale | $18.07 | 9,169 | 165,703 | 9,458 | Nov 22, 2016, 05:57 PM |
LeBel Carl | Chief Scientific Officer | Dec 01, 2015 | Option Exercise | $13.60 | 263 | 3,577 | 9,183 | Sep 08, 2016, 06:55 PM |
LeBel Carl | Chief Scientific Officer | Jun 01, 2016 | Option Exercise | $13.13 | 275 | 3,611 | 9,458 | Sep 08, 2016, 06:55 PM |
LeBel Carl | Chief Scientific Officer | Sep 06, 2016 | Option Exercise | $5.54 | 21,250 | 117,752 | 30,708 | Sep 08, 2016, 06:55 PM |
LeBel Carl | Chief Scientific Officer | Sep 06, 2016 | Sale | $17.95 | 21,250 | 381,438 | 18,575 | Sep 08, 2016, 06:55 PM |
LeBel Carl | Chief Scientific Officer | Dec 21, 2015 | Option Exercise | $5.63 | 21,250 | 119,743 | 30,170 | Dec 22, 2015, 06:23 PM |
LeBel Carl | Chief Scientific Officer | Dec 21, 2015 | Sale | $28.04 | 21,250 | 595,827 | 16,981 | Dec 22, 2015, 06:23 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Dec 17, 2015 | Option Exercise | $6.33 | 3,000 | 18,990 | 12,610 | Dec 18, 2015, 08:00 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Dec 17, 2015 | Sale | $29.70 | 3,000 | 89,101 | 9,910 | Dec 18, 2015, 08:00 PM |
Weber David Allen | President & CEO | Dec 15, 2015 | Option Exercise | $1.76 | 5,208 | 9,166 | 22,811 | Dec 16, 2015, 06:34 PM |
Weber David Allen | President & CEO | Dec 15, 2015 | Sale | $27.25 | 5,208 | 141,917 | 17,603 | Dec 16, 2015, 06:34 PM |
Savel Robert Michael II | Chief Technical Officer | Dec 14, 2015 | Option Exercise | $4.88 | 5,000 | 24,393 | 6,256 | Dec 16, 2015, 06:32 PM |
Savel Robert Michael II | Chief Technical Officer | Dec 14, 2015 | Sale | $26.00 | 5,000 | 129,976 | 3,934 | Dec 16, 2015, 06:32 PM |
ORBIMED ADVISORS LLC | Director | Nov 25, 2015 | Sale | $28.91 | 34,800 | 1,006,068 | 1,882,400 | Nov 30, 2015, 06:55 PM |
ORBIMED ADVISORS LLC | Director | Nov 30, 2015 | Sale | $28.74 | 3,306 | 95,026 | 1,850,684 | Nov 30, 2015, 06:55 PM |
ORBIMED ADVISORS LLC | Director | Nov 27, 2015 | Sale | $28.97 | 29,000 | 840,130 | 1,853,400 | Nov 30, 2015, 06:55 PM |
Khuong Chau Quang | Director | Nov 30, 2015 | Sale | $28.74 | 3,306 | 95,026 | 1,850,684 | Nov 30, 2015, 06:50 PM |
Khuong Chau Quang | Director | Nov 27, 2015 | Sale | $28.97 | 29,000 | 840,130 | 1,853,400 | Nov 30, 2015, 06:50 PM |
Khuong Chau Quang | Director | Nov 25, 2015 | Sale | $28.91 | 34,800 | 1,006,068 | 1,882,400 | Nov 30, 2015, 06:50 PM |
Khuong Chau Quang | Director | Nov 20, 2015 | Sale | $28.59 | 83,900 | 2,398,701 | 2,034,100 | Nov 24, 2015, 08:37 PM |
Khuong Chau Quang | Director | Nov 24, 2015 | Sale | $28.75 | 36,100 | 1,037,875 | 1,917,200 | Nov 24, 2015, 08:37 PM |
Khuong Chau Quang | Director | Nov 23, 2015 | Sale | $28.45 | 80,800 | 2,298,760 | 1,953,300 | Nov 24, 2015, 08:37 PM |
ORBIMED ADVISORS LLC | Director | Nov 24, 2015 | Sale | $28.75 | 36,100 | 1,037,875 | 1,917,200 | Nov 24, 2015, 08:31 PM |
ORBIMED ADVISORS LLC | Director | Nov 23, 2015 | Sale | $28.45 | 80,800 | 2,298,760 | 1,953,300 | Nov 24, 2015, 08:31 PM |
ORBIMED ADVISORS LLC | Director | Nov 20, 2015 | Sale | $28.59 | 83,900 | 2,398,701 | 2,034,100 | Nov 24, 2015, 08:31 PM |
ORBIMED ADVISORS LLC | Director | Nov 19, 2015 | Sale | $28.60 | 127,300 | 3,640,780 | 2,118,000 | Nov 19, 2015, 08:39 PM |
ORBIMED ADVISORS LLC | Director | Nov 17, 2015 | Sale | $28.81 | 11,098 | 319,680 | 2,245,500 | Nov 19, 2015, 08:39 PM |
Khuong Chau Quang | Director | Nov 19, 2015 | Sale | $28.60 | 127,300 | 3,640,780 | 2,118,000 | Nov 19, 2015, 08:32 PM |
Khuong Chau Quang | Director | Nov 17, 2015 | Sale | $28.81 | 11,098 | 319,680 | 2,245,500 | Nov 19, 2015, 08:32 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Nov 17, 2015 | Option Exercise | $6.33 | 3,000 | 18,990 | 12,610 | Nov 17, 2015, 08:09 PM |
Cayer Paul E | Ch. Financial & Business Offcr | Nov 17, 2015 | Sale | $28.69 | 3,000 | 86,057 | 9,610 | Nov 17, 2015, 08:09 PM |
Weber David Allen | President & CEO | Nov 16, 2015 | Option Exercise | $1.76 | 5,208 | 9,166 | 22,811 | Nov 17, 2015, 08:08 PM |
Weber David Allen | President & CEO | Nov 16, 2015 | Sale | $28.57 | 5,208 | 148,812 | 17,703 | Nov 17, 2015, 08:08 PM |
Weber David Allen | President & CEO | Nov 13, 2015 | Option Exercise | $1.76 | 10,416 | 18,332 | 10,955 | Nov 13, 2015, 07:59 PM |
Weber David Allen | President & CEO | Nov 13, 2015 | Sale | $30.95 | 10,416 | 322,375 | 539 | Nov 13, 2015, 07:59 PM |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | Nov 11, 2015 | Option Exercise | $4.12 | 3,000 | 12,350 | 12,610 | Nov 12, 2015, 08:46 PM |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | Nov 11, 2015 | Sale | $24.95 | 3,000 | 74,850 | 9,610 | Nov 12, 2015, 08:46 PM |
Weber David Allen | President & CEO | Nov 11, 2015 | Option Exercise | $1.76 | 5,208 | 9,166 | 5,747 | Nov 12, 2015, 08:45 PM |
Weber David Allen | President & CEO | Nov 11, 2015 | Sale | $24.95 | 5,208 | 129,940 | 539 | Nov 12, 2015, 08:45 PM |
LeBel Carl | Chief Scientific Officer | Sep 21, 2015 | Option Exercise | $5.43 | 21,250 | 115,469 | 30,170 | Sep 22, 2015, 07:01 PM |
LeBel Carl | Chief Scientific Officer | Sep 21, 2015 | Sale | $24.36 | 21,250 | 517,576 | 8,920 | Sep 22, 2015, 07:01 PM |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | Sep 17, 2015 | Option Exercise | $1.76 | 3,000 | 5,280 | 12,610 | Sep 18, 2015, 07:05 PM |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | Sep 17, 2015 | Sale | $24.95 | 3,000 | 74,850 | 9,610 | Sep 18, 2015, 07:05 PM |
Weber David Allen | President & CEO | Sep 15, 2015 | Option Exercise | $1.76 | 5,216 | 9,180 | 5,755 | Sep 16, 2015, 05:17 PM |
Weber David Allen | President & CEO | Sep 15, 2015 | Sale | $24.95 | 5,216 | 130,139 | 539 | Sep 16, 2015, 05:17 PM |
Savel Robert Michael II | Chief Technical Officer | Sep 14, 2015 | Option Exercise | $4.88 | 5,000 | 24,397 | 6,256 | Sep 15, 2015, 05:50 PM |
Savel Robert Michael II | Chief Technical Officer | Sep 14, 2015 | Sale | $23.98 | 5,000 | 119,896 | 1,256 | Sep 15, 2015, 05:50 PM |
Savel Robert Michael II | Chief Technical Officer | Jun 15, 2015 | Option Exercise | $4.46 | 25,000 | 111,581 | 26,256 | Jun 17, 2015, 08:06 PM |
Savel Robert Michael II | Chief Technical Officer | Jun 15, 2015 | Sale | $23.73 | 25,000 | 593,285 | 1,256 | Jun 17, 2015, 08:06 PM |
Weber David Allen | President & CEO | Jun 01, 2015 | Option Exercise | $13.60 | 539 | 7,330 | 539 | Jun 02, 2015, 09:01 PM |
Savel Robert Michael II | Chief Technical Officer | Jun 01, 2015 | Option Exercise | $13.60 | 1,256 | 17,082 | 1,256 | Jun 02, 2015, 08:59 PM |
LeBel Carl | Chief Scientific Officer | Jun 01, 2015 | Option Exercise | $13.60 | 389 | 5,290 | 389 | Jun 02, 2015, 08:58 PM |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | Jun 01, 2015 | Option Exercise | $13.60 | 2,500 | 34,000 | 2,500 | Jun 02, 2015, 08:57 PM |
CAPPS VICKIE L | Director | May 22, 2015 | Buy | $24.35 | 1,600 | 38,960 | 1,600 | May 27, 2015, 05:16 PM |
CAPPS VICKIE L | Director | May 22, 2015 | Buy | $24.36 | 3,400 | 82,808 | 3,400 | May 27, 2015, 05:16 PM |
Novo A/S | 10% Owner | Aug 19, 2014 | Buy | $15.50 | 15,690 | 243,135 | 2,175,025 | Aug 21, 2014, 05:15 PM |
MCKEARN JOHN P | Director | Aug 18, 2014 | Sale | $8.79 | 25,000 | 219,750 | 794,177 | Aug 19, 2014, 07:35 PM |
MCKEARN JOHN P | Director | Aug 18, 2014 | Option Exercise | $8.79 | 45,505 | 399,989 | 813,837 | Aug 19, 2014, 07:35 PM |
Avalon Ventures VIII LP | 10% Owner | Aug 18, 2014 | Buy | $16.00 | 109,375 | 1,750,000 | 814,973 | Aug 19, 2014, 07:34 PM |
Avalon Ventures VIII LP | 10% Owner | Aug 18, 2014 | Sale | $16.00 | 50,001 | 800,016 | 1,450,179 | Aug 19, 2014, 07:34 PM |
Avalon Ventures VIII LP | 10% Owner | Aug 18, 2014 | Option Exercise | $8.79 | 91,011 | 799,987 | 1,500,180 | Aug 19, 2014, 07:34 PM |
Weber David Allen | President & CEO | Aug 18, 2014 | Option Exercise | $8.79 | 113 | 993 | 4,812 | Aug 19, 2014, 07:31 PM |
ORBIMED ADVISORS LLC | 10% Owner | Aug 18, 2014 | Buy | $16.00 | 171,875 | 2,750,000 | 2,256,398 | Aug 19, 2014, 07:30 PM |
Khuong Chau Quang | Director | Aug 18, 2014 | Buy | $16.00 | 171,875 | 2,750,000 | 2,256,398 | Aug 19, 2014, 07:29 PM |
Lichter Jay | Director | Aug 18, 2014 | Buy | $16.00 | 109,375 | 1,750,000 | 814,973 | Aug 19, 2014, 07:27 PM |
Lichter Jay | Director | Aug 18, 2014 | Sale | $16.00 | 50,001 | 800,016 | 1,450,179 | Aug 19, 2014, 07:27 PM |
Lichter Jay | Director | Aug 18, 2014 | Option Exercise | $8.79 | 91,011 | 799,987 | 1,500,180 | Aug 19, 2014, 07:27 PM |
Novo A/S | 10% Owner | Aug 18, 2014 | Buy | $16.00 | 171,875 | 2,750,000 | 2,159,335 | Aug 19, 2014, 04:52 PM |
DP VIII Associates, L.P. | 10% Owner | Aug 18, 2014 | Option Exercise | $16.00 | 277 | 4,432 | 11,715 | Aug 18, 2014, 05:37 PM |
DP VIII Associates, L.P. | 10% Owner | Aug 18, 2014 | Option Exercise | $8.79 | 502 | 4,413 | 11,992 | Aug 18, 2014, 05:37 PM |
Domain Partners VIII, L.P. | 10% Owner | Aug 18, 2014 | Option Exercise | $16.00 | 37,224 | 595,584 | 1,579,323 | Aug 18, 2014, 05:29 PM |
Domain Partners VIII, L.P. | 10% Owner | Aug 18, 2014 | Option Exercise | $8.79 | 67,755 | 595,566 | 1,616,547 | Aug 18, 2014, 05:29 PM |
Owner | Relationship | Date | Value($) |
Weber David Allen | Director | 12/30/2022 | 8,064 |
Cayer Paul E | President and CFBO | 12/28/2022 | 3,485 |
CAPPS VICKIE L | Director | 11/28/2022 | 4,342 |
Weber David Allen | President & CEO | 03/28/2022 | 27,129 |
Weber David Allen | President & CEO | 03/25/2022 | 19,166 |
Savel Robert Michael II | Chief Technical Officer | 03/28/2022 | 8,023 |
Savel Robert Michael II | Chief Technical Officer | 03/25/2022 | 5,669 |
Foster Alan Charles | Chief Scientific Officer | 03/28/2022 | 6,175 |
Foster Alan Charles | Chief Scientific Officer | 03/25/2022 | 4,363 |
Cayer Paul E | Ch. Financial & Business Offcr | 03/28/2022 | 13,571 |
Cayer Paul E | Ch. Financial & Business Offcr | 03/25/2022 | 9,588 |
Lichter Jay | Director | 03/03/2021 | 866,544 |
Lichter Jay | Director | 03/01/2021 | 496,087 |
Lichter Jay | Director | 02/26/2021 | 935,468 |
Lichter Jay | Director | 03/02/2021 | 1,129,375 |
Lichter Jay | Director | 02/25/2021 | 918,989 |
Lichter Jay | Director | 02/24/2021 | 1,500,349 |
Lichter Jay | Director | 02/23/2021 | 774,325 |
Lichter Jay | Director | 08/31/2017 | 1,999,593 |
Lichter Jay | Director | 08/31/2017 | 2,000,231 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 06/01/2017 | 13,785 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 12/01/2016 | 8,443 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 06/01/2016 | 13,406 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 12/01/2015 | 13,200 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 06/26/2017 | 22,613 |
LOUMEAU ERIC J | GC & Chief Compliance Officer | 06/23/2017 | 42,846 |
LeBel Carl | Chief Scientific Officer | 11/21/2016 | 4,616 |
LeBel Carl | Chief Scientific Officer | 11/18/2016 | 40,262 |
LeBel Carl | Chief Scientific Officer | 11/21/2016 | 26,303 |
LeBel Carl | Chief Scientific Officer | 11/18/2016 | 165,703 |
LeBel Carl | Chief Scientific Officer | 12/01/2015 | 3,577 |
LeBel Carl | Chief Scientific Officer | 06/01/2016 | 3,611 |
LeBel Carl | Chief Scientific Officer | 09/06/2016 | 117,752 |
LeBel Carl | Chief Scientific Officer | 09/06/2016 | 381,438 |
LeBel Carl | Chief Scientific Officer | 12/21/2015 | 119,743 |
LeBel Carl | Chief Scientific Officer | 12/21/2015 | 595,827 |
Cayer Paul E | Ch. Financial & Business Offcr | 12/17/2015 | 18,990 |
Cayer Paul E | Ch. Financial & Business Offcr | 12/17/2015 | 89,101 |
Weber David Allen | President & CEO | 12/15/2015 | 9,166 |
Weber David Allen | President & CEO | 12/15/2015 | 141,917 |
Savel Robert Michael II | Chief Technical Officer | 12/14/2015 | 24,393 |
Savel Robert Michael II | Chief Technical Officer | 12/14/2015 | 129,976 |
ORBIMED ADVISORS LLC | Director | 11/25/2015 | 1,006,068 |
ORBIMED ADVISORS LLC | Director | 11/30/2015 | 95,026 |
ORBIMED ADVISORS LLC | Director | 11/27/2015 | 840,130 |
Khuong Chau Quang | Director | 11/30/2015 | 95,026 |
Khuong Chau Quang | Director | 11/27/2015 | 840,130 |
Khuong Chau Quang | Director | 11/25/2015 | 1,006,068 |
Khuong Chau Quang | Director | 11/20/2015 | 2,398,701 |
Khuong Chau Quang | Director | 11/24/2015 | 1,037,875 |
Khuong Chau Quang | Director | 11/23/2015 | 2,298,760 |
ORBIMED ADVISORS LLC | Director | 11/24/2015 | 1,037,875 |
ORBIMED ADVISORS LLC | Director | 11/23/2015 | 2,298,760 |
ORBIMED ADVISORS LLC | Director | 11/20/2015 | 2,398,701 |
ORBIMED ADVISORS LLC | Director | 11/19/2015 | 3,640,780 |
ORBIMED ADVISORS LLC | Director | 11/17/2015 | 319,680 |
Khuong Chau Quang | Director | 11/19/2015 | 3,640,780 |
Khuong Chau Quang | Director | 11/17/2015 | 319,680 |
Cayer Paul E | Ch. Financial & Business Offcr | 11/17/2015 | 18,990 |
Cayer Paul E | Ch. Financial & Business Offcr | 11/17/2015 | 86,057 |
Weber David Allen | President & CEO | 11/16/2015 | 9,166 |
Weber David Allen | President & CEO | 11/16/2015 | 148,812 |
Weber David Allen | President & CEO | 11/13/2015 | 18,332 |
Weber David Allen | President & CEO | 11/13/2015 | 322,375 |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | 11/11/2015 | 12,350 |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | 11/11/2015 | 74,850 |
Weber David Allen | President & CEO | 11/11/2015 | 9,166 |
Weber David Allen | President & CEO | 11/11/2015 | 129,940 |
LeBel Carl | Chief Scientific Officer | 09/21/2015 | 115,469 |
LeBel Carl | Chief Scientific Officer | 09/21/2015 | 517,576 |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | 09/17/2015 | 5,280 |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | 09/17/2015 | 74,850 |
Weber David Allen | President & CEO | 09/15/2015 | 9,180 |
Weber David Allen | President & CEO | 09/15/2015 | 130,139 |
Savel Robert Michael II | Chief Technical Officer | 09/14/2015 | 24,397 |
Savel Robert Michael II | Chief Technical Officer | 09/14/2015 | 119,896 |
Savel Robert Michael II | Chief Technical Officer | 06/15/2015 | 111,581 |
Savel Robert Michael II | Chief Technical Officer | 06/15/2015 | 593,285 |
Weber David Allen | President & CEO | 06/01/2015 | 7,330 |
Savel Robert Michael II | Chief Technical Officer | 06/01/2015 | 17,082 |
LeBel Carl | Chief Scientific Officer | 06/01/2015 | 5,290 |
Cayer Paul E | CFO/Ch. Business Offcr & Sec. | 06/01/2015 | 34,000 |
CAPPS VICKIE L | Director | 05/22/2015 | 38,960 |
CAPPS VICKIE L | Director | 05/22/2015 | 82,808 |
Novo A/S | 10% Owner | 08/19/2014 | 243,135 |
MCKEARN JOHN P | Director | 08/18/2014 | 219,750 |
MCKEARN JOHN P | Director | 08/18/2014 | 399,989 |
Avalon Ventures VIII LP | 10% Owner | 08/18/2014 | 1,750,000 |
Avalon Ventures VIII LP | 10% Owner | 08/18/2014 | 800,016 |
Avalon Ventures VIII LP | 10% Owner | 08/18/2014 | 799,987 |
Weber David Allen | President & CEO | 08/18/2014 | 993 |
ORBIMED ADVISORS LLC | 10% Owner | 08/18/2014 | 2,750,000 |
Khuong Chau Quang | Director | 08/18/2014 | 2,750,000 |
Lichter Jay | Director | 08/18/2014 | 1,750,000 |
Lichter Jay | Director | 08/18/2014 | 800,016 |
Lichter Jay | Director | 08/18/2014 | 799,987 |
Novo A/S | 10% Owner | 08/18/2014 | 2,750,000 |
DP VIII Associates, L.P. | 10% Owner | 08/18/2014 | 4,432 |
DP VIII Associates, L.P. | 10% Owner | 08/18/2014 | 4,413 |
Domain Partners VIII, L.P. | 10% Owner | 08/18/2014 | 595,584 |
Domain Partners VIII, L.P. | 10% Owner | 08/18/2014 | 595,566 |